Literature DB >> 26710395

A Clinical Evaluation of Atrial Fibrillation in Rheumatic Heart Disease.

S K Sharma, S H Verma.   

Abstract

OBJECTIVES: To estimate incidence of atrial fibrillation in patients of rheumatic heart disease, to study clinical correlation of atrial fibrillation in term of mitral valve area in mitral stenosis, to estimate incidence of systemic embolization and to find out association of atrial fibrillation with recurrent respiratory infections.
MATERIAL AND METHODS: Ninty-four cases were assigned with different groups according to type of valvular lesion, age group, sex and severity. The incidence of atrial fibrillation was compared among these groups. Patients were grouped according to the type of valvular lesion, age and mitral valve area. Incidence of different types of systemic embolization was studied in cases suffering from atrial fibrillation. We also looked for association of atrial fibrillation with respiratory tract infections.
RESULTS: The incidence of atrial fibrillation was 41 out of 94 cases (43.61%). The highest incidence of atrial fibrillation was in the age group of 21-30 yrs (55%) and the incidence was more in females (72.72%) as compared to males (27.27%). The incidence of atrial fibrillation in patients with pure mitral stenosis was 48.2% and in cases of predominant mitral regurgitation 43.3%. The incidence of atrial fibrillation in cases of mitral stenosis with mitral valve area < 1 cm2 was 70.4% as compared to 29.6% in cases of mitral stenosis with mitral valve area > 1 cm2. Out of 41 cases of atrial fibrillation, nine had evidence of systemic embolization out of which six were cerebral (66.66%), two were peripheral (33.33%) and one was mesenteric (16.66%). The respiratory infections were more commonly present in patients with atrial fibrillation as compared to patients without atrial fibrillation (24.39% Vs 5.66%).
CONCLUSIONS: The incidence of atrial fibrillation is significant in cases of rheumatic heart disease. The incidence is higher in females and in the age group of 21-30 yrs. The incidence of atrial fibrillation increases with severity of valvular stenosis. Systemic embolization is present in significant number of patients with rheumatic heart disease with atrial fibrillation. Cerebral embolization is more common as compared to peripheral and followed by mesenteric. The respiratory tract infection is more commonly present in patients with atrial fibrillation as compared to patients without atrial fibrillation.

Entities:  

Mesh:

Year:  2015        PMID: 26710395

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  8 in total

1.  Prevalence of atrial fibrillation in an urban population in India: the Nagpur pilot study.

Authors:  Daljeet Kaur Saggu; Gomathi Sundar; Sandeep G Nair; Varun C Bhargava; Krishnamohan Lalukota; Sridevi Chennapragada; Calambur Narasimhan; Sumeet S Chugh
Journal:  Heart Asia       Date:  2016-04-18

2.  Long-term outcomes of radiofrequency catheter ablation for atrial fibrillation in rheumatic heart disease patients with mild mitral stenosis.

Authors:  Jindong Chen; Hao Wang; Liang Zhao
Journal:  J Interv Card Electrophysiol       Date:  2019-05-04       Impact factor: 1.900

3.  Rheumatic Heart Disease with Multiple Systemic Emboli: A Rare Occurrence in a Single Subject.

Authors:  Ravi R Pradhan; Ashish Jha; Gaurav Nepal; Manju Sharma
Journal:  Cureus       Date:  2018-07-11

4.  Comparative Clinical Characteristics of Rheumatic Heart Disease Patients Undergoing Surgical Valve Replacement.

Authors:  Hamza I Butt; Ahmad Shahbaz; Haroon Nawaz; Khurram Butt
Journal:  Cureus       Date:  2019-06-12

5.  A pilot study on the acute conversion and maintenance of sinus rhythm in rheumatic atrial fibrillation using oral flecainide.

Authors:  Anindya Ghosh; Aditya Kapoor; Roopali Khanna; Ankit Sahu; Sudeep Kumar; Naveen Garg; Satyendra Tewari; Pravin Goel
Journal:  Indian Heart J       Date:  2020-07-14

6.  Role of inflammation in initiation and maintenance of atrial fibrillation in rheumatic mitral stenosis - An analytical cross-sectional study.

Authors:  Gautam Sharma; Nirmal Ghati; Mohd Sharique; Shruti Sharma; Sudhir Shetkar; Suman Karmakar; Nitish Naik; Ramakrishnan Lakshmy; Bhaskar Thakur; Aman Agarwal; Anita Saxena
Journal:  J Arrhythm       Date:  2020-09-04

7.  2021 Asia Pacific Heart Rhythm Society (APHRS) practice guidance on atrial fibrillation screening.

Authors:  Ngai-Yin Chan; Jessica Orchard; Michael-Joseph Agbayani; Dean Boddington; Tze-Fan Chao; Sofian Johar; Bobby John; Boyoung Joung; Saravanan Krishinan; Rungroj Krittayaphong; Sayaka Kurokawa; Chu-Pak Lau; Toon Wei Lim; Pham Tran Linh; Vien Hoang Long; Ajay Naik; Yasuo Okumura; Tetsuo Sasano; Bernard Yan; Sunu Budhi Raharjo; Dicky Armein Hanafy; Yoga Yuniadi; Nwe Nwe; Zahid Aslam Awan; He Huang; Ben Freedman
Journal:  J Arrhythm       Date:  2021-12-28

Review 8.  Meta-Analysis of the Incidence, Prevalence, and Correlates of Atrial Fibrillation in Rheumatic Heart Disease.

Authors:  Jean Jacques Noubiap; Ulrich Flore Nyaga; Aude Laetitia Ndoadoumgue; Jan René Nkeck; Anderson Ngouo; Jean Joel Bigna
Journal:  Glob Heart       Date:  2020-05-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.